Načítá se...
Synergism of Heat Shock Protein 90 and Histone Deacetylase Inhibitors in Synovial Sarcoma
Current systemic therapies have little curative benefit for synovial sarcoma. Histone deacetylase (HDAC) inhibitors and the heat shock protein 90 (Hsp90) inhibitor 17-AAG have recently been shown to inhibit synovial sarcoma in preclinical models. We tested combinations of 17-AAG with the HDAC inhibi...
Uloženo v:
Hlavní autoři: | , , , , |
---|---|
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
Hindawi Publishing Corporation
2009
|
Témata: | |
On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2659882/ https://ncbi.nlm.nih.gov/pubmed/19325926 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2009/794901 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|